Versigent VGNT

Current Stats

Post-Spinoff Performance

Computed from split-adjusted closing prices. Returns are total return — (end price + dividends received − start price) ÷ start price — with no reinvestment assumed.

Post-Spin Analysis — August 25, 2026

Written against the August 24 close of $46.96. Primary sources: the Q2 2026 Form 10-Q (filed 2026-08-04), the Q1 2026 Form 10-Q, and the Form 10 information statement, which carries three years of audited carve-out financials. No annual report exists yet — Versigent began trading on April 1, 2026.

The one-line version

Versigent is up 68.6% since the April spin and still trades at 4.9x EV/EBITDA and roughly 7.4x normalized earnings — below BorgWarner at ~7.5x EV/EBITDA, below the 5.5–8.5x range for Tier-1 supplier transactions, and below the 8–12x P/E where auto suppliers usually trade.

The cheapness is real. The growth story is thinner than two quarters make it look. The Form 10 carries three years of carve-out history, and over that period revenue went $8,832M → $8,309M → $8,818M — a −0.1% CAGR. The 10.8% growth reported last quarter is a recovery off a weak 2024, not an established trend.

Adjusted operating margin tells the same story: 7.6% → 6.9% → 7.6% across the three years, then 7.9% in 1H26 and 9.0% in Q2. That last quarter is the best in the company’s recorded history — but it is one quarter, and Q1 2026 was down year on year.

Rating BUY. Target $62. Base case +36%; the bear case — flat revenue forever at the three-year average margin — is roughly fair value, not a loss. You are paying a distressed multiple for a business that has proven it can earn ~7.5% margins through a cycle, with a free option on the Q2 improvement being real.

The distribution is wider than that in both directions. The upside tails — the restructuring program genuinely ending, working capital reversing, capital return beginning — are worth $73–95. The downside tails are faster: losing one of three customers at 14–20% of sales is worth −31% to −57%, and ~$102M of hedge gains currently flowing through cost of sales will not repeat. See Tail scenarios.

Grade B+ (3.20).

What the business actually is

The electrical distribution business separated from Aptiv on April 1, 2026 — wiring harnesses, connectors and the signal, power and data architecture that runs through a vehicle. Roughly $9.3B of annualised revenue, making it one of the largest names in the tracked universe by sales and one of the smallest by market capitalization.

Read that table before anything else. The market’s assumption about this industry is that high-voltage architecture — the EV-linked business — is the growth story and traditional low-voltage wiring is the melting ice cube. Versigent’s numbers say the reverse. High voltage is 9% of sales and shrinking 15%; low voltage is 91% and growing 14%.

Geographically it is genuinely global: North America $1,022M, EMEA $524M, with the balance in Asia Pacific and South America. Manufacturing is labor-intensive and sited accordingly, which is both the margin structure and the tariff exposure.

Management also flags adjacent markets — agriculture, construction, grid and infrastructure, off-grid power storage and robotics. Nothing is sized yet, so it is optionality rather than a number.

Management Team

The CEO already ran this business. That is a different proposition from an outside hire learning a spun-off asset — the Q2 margin step-up came from someone who knew where the cost was before the separation.

The pairing is otherwise conventional: an operator who knows the assets and a finance executive brought in from outside. Two quarters is not a track record, and the scorecard reflects that.

The financial record, over three years rather than two quarters

The Form 10 carries audited carve-out financials back to 2023. They are essential context, and they temper the story the quarterly numbers tell.

Adjusted for amortization, restructuring, separation costs, acquisition and portfolio project costs, and asset impairments, per the Form 10 reconciliation.

Three things the longer record establishes:

1. Revenue has been flat, not growing. 2023 to 2025 is a −0.1% CAGR. Revenue fell 5.9% in 2024 and recovered 6.1% in 2025 — back to roughly where it started. The 10.8% growth in Q2 2026 is measured against a soft comparison, and 1H 2026 revenue of $4,656M annualises to $9.3B, which would be the first year genuinely above the 2023 level.

2. Margin is cyclical around ~7.5%, not on a trend. 7.6% → 6.9% → 7.6%. The 1H26 figure of 7.9% is modestly above that band and Q2’s 9.0% is the best quarter in the record — but the annual pattern is a business that earns roughly 7.5% through a cycle and dips in bad years.

3. Restructuring is persistent, which makes “adjusted” generous. Restructuring charges ran $48M, $101M and $86M across the three years — roughly 1% of sales, every year. A cost that recurs annually is arguably an operating cost rather than an adjustment. Strip it out entirely and the margins read 7.1% / 5.7% / 6.6%.

What is genuinely new, and worth watching

Q2 2026 carried zero restructuring charges — the first clean quarter in the record — and delivered a 9.0% adjusted margin on 10.8% revenue growth. That is a real result, and it is why the stock rose 8.9% the day it was reported.

But Q1 2026’s adjusted margin was 6.6%, down from 7.1% a year earlier. One quarter up sharply, one quarter down. Q3 is the test, and the valuation below deliberately does not require the 9.0% to hold.

Where Versigent sits in the value chain

This is a genuinely weak bargaining position, and the valuation is arguably the correct response to it rather than an inefficiency. Establishing it properly matters, because the bull case rests on 4.9x being too cheap.

What protects it is cost position, not pricing power

A harness is designed into a specific vehicle platform. It is engineered around that model’s architecture, routing and packaging; switching supplier mid-program is close to impossible. That protects the revenue for the five to seven years a platform runs.

It confers nothing at the rebid. When the next platform is awarded, the OEM runs a competitive process among four or five capable global suppliers, and the winner is whoever can build it cheapest at the required quality. Design-in protects the program; it does not protect the price.

The same distinction separates two other recent industrial separations, and Versigent sits at the harder end of it. Solstice’s refrigerant business is protected by scarcity — a patent on a molecule regulation obliges the customer to buy — and it raises price. Qnity is protected by qualification — the socket is safe, but four to six suppliers are qualified and the buyer is TSMC, so it gives price back. Versigent is protected by neither. It is protected by being the low-cost producer, which is a real advantage and a completely different one: it defends margin rather than creating it.

That is why the margin is what it is. Adjusted operating margin of 7.6% → 6.9% → 7.6% across three years is not a business failing to expand. It is a business being held at a cost-plus outcome by customers who can see its cost base, and the stability of that number across a cycle is the evidence.

The tailwind is content, not units

Global vehicle production is flat to declining. Versigent’s content per vehicle is not. Every additional sensor, camera, display, domain controller and electrified subsystem adds wiring, connectors and signal architecture. The shift toward zonal electrical architectures is a redesign of exactly what this company sells.

That is the growth mechanism, and it is more durable than the volume line suggests — it does not require anyone to build more cars, only to put more electronics in the ones they build.

And the page’s most contrarian finding sits here. Low-voltage architecture is 91% of sales and grew 14.2%; high-voltage — the EV-linked business — is 9% and shrank 14.9%. The market’s model of this industry is that high voltage is the growth engine and low voltage the melting ice cube. On Versigent’s numbers that is backwards, and the reason is content: hybrids and conventional vehicles are gaining electronics faster than EV volumes are growing.

So is 4.9x wrong, or right?

Partly right, and that is the honest answer. A business that cannot raise price, has three customers at 14–20%, and competes on manufacturing cost should trade below a supplier with proprietary technology. The 8–12x where auto suppliers usually trade is not the right benchmark for the weakest position in the sector.

But 4.9x is below even its own tier. BorgWarner trades near 7.5x, and Tier-1 supplier transactions have cleared at 5.5–8.5x. The discount to those is what has to be explained, and the candidates are the customer concentration, the hedge gains that will not repeat, the flat three-year revenue line, and five months of listed history. Those are reasons for a discount to the sector. They are not obviously reasons for a discount to the discount — which is the whole of the bull case, stated precisely.

Why the stock has re-rated

There is no single event in the price history. The move is a grind:

Day-1 close $27.85 · post-spin low $26.94 on April 7, six sessions in · all-time high $50.17 on June 4 · now 6.4% below that high and 74.3% above the low.

The forced-selling flush was shallow and fast. Day-1 volume ran 25.6x the eventual baseline, the low arrived on session six at just 3.3% below the day-1 close, and volume now runs 0.74x baseline. The mechanical seller was done inside two weeks.

Every one of the seven largest single-session moves is positive, and all came on modest volume — 1.3x to 2.3x normal. The two largest, +10.8% on May 6 and +8.9% on August 4, are the days after the two quarterly reports. This is a business re-rating on results, not a story stock.

Realised volatility is 58.9% annualised, which is high and matters for position sizing.

Valuation

Debt structure: $500M Term Loan A due 2031, 6.125% senior notes due 2031, 6.375% senior notes due 2034, and an undrawn $850M revolver. Nothing matures before 2031.

Cash conversion is the weak spot, and it is real

The gap is working capital: receivables absorbed $278M in the first half against $426M of incremental revenue, partly offset by payables. This is a business that consumes cash as it grows, and the faster it grows the more it consumes. Capex is modest at 2.5% of sales and depreciation is 2.4%, so this is a working-capital story, not a capital-intensity one.

The valuation below charges for it: the model applies a 14-cent working-capital absorption on every incremental revenue dollar.

The capital-spending half of the story is set out separately below, and it runs the other way: capex was cut a third in the two years before the spin and is now rising, which flatters the 2025 free-cash-flow figure and depresses this one. Neither 21% nor the 2025 number is the run-rate.

Discounted cash flow

Every assumption is stated, because on a business with three years of history and two quarters of public reporting the assumptions are the analysis.

Scenarios

The bear case is roughly fair value, not a loss. That is the honest version of the asymmetry: you are not being paid to take a large downside, you are being paid because the downside is small.

Tail scenarios — the outcomes outside the base/bull/bear frame

The scenarios above vary growth and margin within a plausible band. These are the low-probability outcomes that are still specific and foreseeable — not black swans, but the two-to-three-standard-deviation cases with identifiable causes. They are listed because the distribution here is genuinely wider than the base case implies, in both directions.

Upside tails

1. The restructuring program actually ends. Charges ran $48M, $101M and $86M across 2023–25, and Q2 2026 was the first quarter in the record with zero. If that is a program completing rather than a pause, reported margin converges toward adjusted permanently: +$86M pre-tax, +$0.96 of EPS, and normalized EPS goes $6.31 → $7.26. At 10x that is $73 rather than $63. This is the single most likely of the tails, and Q3 will show it.

2. The margin trend is real and continues. The sequence is 7.6% → 6.9% → 7.6% → 7.9% → 9.0%. If 9.0% is the new base and scale plus adjacent-market mix carries it toward 10%:

3. Working capital stops absorbing cash. Free-cash-flow conversion was 21% in 1H26 because receivables took $278M as sales grew. That is a growth cost, not a structural one — if growth moderates it reverses:

4. Capital return begins. No dividend or buyback has been declared. At 45% conversion, a 50% payout is a 5% dividend yield, and retiring 5% of the shares a year adds roughly 5% to EPS annually. For a company at 7.4x earnings that is a material re-rating trigger on its own.

5. The adjacent markets get sized. Management names agriculture, construction, grid and infrastructure, off-grid power storage and robotics. None is quantified anywhere. Power and data distribution for data-center build-out is the same engineering problem as a vehicle harness, and it is the largest capital-spending program in the industrial economy right now. If any of this is disclosed as a real number, it changes the multiple rather than the earnings.

Downside tails

1. Losing one of the three large customers. Three names are 20%, 18% and 14% of sales. Operating leverage makes the consequence non-linear, because the terminal and engineering base does not shrink with the volume:

A 20% revenue loss takes roughly half the operating income. This is the single largest risk on this page and it is why the position sizing note exists.

2. The hedge gains reverse — and this one is already dated. The 10-Q discloses $125M of net gains on cash flow hedges sitting in AOCI, of which approximately $102M is scheduled to flow into cost of sales over the next twelve months. That is 1.1% of sales — roughly 1.1 percentage points of operating margin — and it is temporary.

Part of the margin improvement this analysis is valuing may be a hedge gain rather than an operating gain. Strip the full 1.1pp and normalized margin falls 7.9% → 6.8%, EPS $6.82 → $5.68, and a 10x multiple gives $57 instead of $68. The hedges extend only to June 2028, after which the company reprices at spot.

This does not invalidate the thesis — $57 is still above today’s price — but it is the most concrete reason the Q2 margin may not be what it appears, and it is more specific than “one quarter is not a trend.”

3. Peso or tariff shock. The company hedges $1,022M notional of Mexican peso and 57.6M pounds of copper ($354M notional). The peso figure reveals how much of the cost base is Mexican labor. Beyond the hedge horizon:

4. Both at once. A vehicle-production downturn of 10% with the hedge benefit rolling off puts margin near 6.2% — the 2024 level minus the hedge — for EPS of $4.41 and roughly $35 at 8x, or −25%.

What the tails say about the position

The upside tails are larger and more numerous than the downside tails, but the downside tails are faster. A customer loss is a single announcement; the margin trend proving durable takes four quarters to establish.

That argues for exactly what the sizing note says: own it, size it for the customer-concentration case, and let the Q3 and Q4 prints resolve whether the upside tails are live.

Earnings-based valuation

For a mature, cyclical manufacturer, earnings are as informative as cash flow — and here they need one adjustment. Versigent’s carve-out history carries no interest expense, because Aptiv’s debt was never attributed to it. Every figure below is pro-forma for the ~$144M of annual interest on the $2.2B raised at separation.

Auto-component suppliers typically trade at 8–12x forward earnings. Versigent trades at 7.4x on its three-year average margin — below the range on the most conservative earnings basis available, before crediting any of the recent improvement.

What a peer multiple implies, on normalized EPS of $6.31:

The DCF and the earnings work agree: $63–64 on mid-range assumptions, which is where the target below sits.

Price target: $62 · range $50–75 · BUY

Method	Value
DCF — 11.5% WACC, 6x exit EV/EBITDA	$64
10x P/E on normalized EPS of $6.31	$63
9x P/E on normalized EPS	$57
6.5x EV/EBITDA on FY26E	$71
Margin reverts to the three-year average	$54
Bear — flat revenue forever at 7.4% margin	$46

Base $62 is +32% to the August 24 close. Two independent methods — a discounted cash flow and a peer earnings multiple — land within a dollar of each other.

Recommendation: BUY, and the reason is the shape of the distribution rather than the size of the upside. The bear case is roughly today’s price. Flat revenue in perpetuity at the margin this business earned through 2023–2025 is worth about what you pay now. Everything better than that — the market’s 2% growth, any of the share gains of the last two quarters, any part of the Q2 margin proving durable — is upside you are not paying for.

What you are buying: a global Tier-1 supplier at 7.4x normalized earnings and 4.9x EV/EBITDA, with an undrawn $850M revolver, nothing maturing before 2031, and a management team that already ran the business inside Aptiv.

What you are underwriting: that 52% customer concentration does not bite, that flat is the floor rather than the trend, and that a labor-intensive manufacturer holds price through a tariff cycle.

Why the target does not move on the hedge finding. The tail analysis shows ~$102M of hedge gains flowing into cost of sales over the next twelve months — about 1.1pp of margin. That is a reason Q2’s 9.0% overstates the run-rate, and this valuation already declines to extrapolate it: the normalized EPS of $6.31 is built on the three-year average margin of 7.4%, a period that contains its own hedge gains and losses through a cycle. The finding reinforces the conservative anchor rather than undermining it. It does mean the upside tails require the operating improvement to be real, not hedged.

Sizing note. 58.9% realised volatility, three customers at half of revenue, and a three-year revenue record that is flat. The asymmetry justifies a position; none of the above justifies a large one.

What this most resembles

Matching on the characteristics that should drive the outcome — an asset-heavy, labor-intensive vehicle-component business spun from a parent repositioning toward higher-multiple technology — the universe offers a small and pointed set.

One of four beat the S&P; median excess −6.5pp. Vehicle-supplier spinoffs are not a good category on average, and two of the four drew down more than 90%.

PHINIA is the analog that matters

BorgWarner spun its fuel systems and aftermarket business in July 2023 — the internal-combustion parts that the market had written off as terminal in an electrifying world. It is up 102.5%, beating the index by 12 percentage points annualised.

The trade was that the market mispriced a “declining” legacy business. Versigent is the same shape: 91% of its revenue is traditional low-voltage wiring, the part investors assume is being displaced, and it is growing 14% while the high-voltage EV business shrinks.

The difference cuts in Versigent’s favor on cyclicality — PHINIA carried more aftermarket revenue, which is steadier than OEM production. It cuts against on concentration.

Garrett Motion is in the table but is not a true comparable

It is included because it screens as one — a cheap component supplier spun from a large industrial parent — and because excluding it silently would flatter the cohort. But it failed for a reason that has nothing to do with turbochargers.

Garrett was spun from Honeywell in October 2018 carrying an indemnity obligation of roughly $1.5 billion, requiring it to pay Honeywell 90% of asbestos liabilities arising from the legacy Bendix brake business. Garrett sued its former parent in December 2019, alleging the spin-off was devised to offload those liabilities and that the agreement was not negotiated at arm’s length. It filed for Chapter 11 in September 2020, and the reorganization eliminated the indemnity in exchange for a $375M cash payment and preferred stock issued to Honeywell.

That is a different category of transaction — a parent disposing of a legal liability using an operating business as the vehicle. Judged on operations Garrett was viable; it was the parent agreement that broke it.

The relevant question for Versigent is therefore narrow: does it carry anything similar? The Form 10 and both 10-Qs disclose no indemnity of that character. What it carries is ordinary: $2,224M of debt at 6.125%–6.375%, nothing due before 2031, an undrawn $850M revolver and 1.63x leverage. Excluding Garrett from the operating comparison, the auto-supplier cohort is PHINIA, Solventum and Adient — one of three beat.

Capital allocation

The page has treated cash conversion as a working-capital story. The three-year record says capital spending is the other half of it, and that half was flattered going into the separation.

Capex was cut by a third into the spin, and is now going back up

Capital expenditure fell 34% across 2023–2025 — $244M to $160M — and dropped to 73% of depreciation in the final year under Aptiv. In the first half of 2026 it is running $117M against $79M, up 48% year on year and back above depreciation.

That reframes the free-cash-flow figures on both sides. The $481M reported for 2025 was earned partly by underspending; the $77M for the first half of 2026 is depressed partly by catching up. Neither number is the run-rate, and the existing 21% conversion figure on this page is the low end of a range rather than a level.

It is a recognizable pattern — capital spending trimmed in the years a parent prepares to separate a business, then normalizing afterwards. It is not evidence of anything improper; it is a reason to discount the pre-spin cash flow and to expect the post-spin figure to be worse before it is better.

The separation moved $1.9B to Aptiv and left almost no equity behind

Total shareholders’ equity is $284M, of which $199M is a noncontrolling interest — leaving $85M attributable to Versigent shareholders against $5,359M of total assets. That is not negative book equity, but it is close, and it is the mechanical result of the same structure seen at every levered separation in this set.

The debt is expensive, and the credit market agrees with the equity market

A 6.2% blended coupon is high for a borrower of this size with no maturity before 2031. Lenders priced it off the same facts the equity market did: thin margins, three customers at 14–20% of sales, and no ability to set price. That is a useful cross-check on the “too cheap” thesis — two independent markets reached the same view of the risk, and neither of them is the stock price.

The maturity profile is comfortable: nothing due before 2031, an undrawn $850M revolver, and covenant compliance confirmed.

Nothing is being returned, and something was promised

The Form 10 states plainly: “We currently expect to pay regular dividends to our shareholders following the Spin-Off.” Five months on, no dividend has been declared and no repurchase authorization exists. The only distribution in the cash flow statement is $4M to minority shareholders of consolidated affiliates — not to Versigent’s own holders.

This is the clearest near-term test of management’s confidence. The company said it intended to pay a regular dividend, generated $481M of free cash flow in its final year under Aptiv, and has not initiated one. Either the cash conversion is not yet trusted to support it, or the capital-spending catch-up comes first. Both are defensible. Neither is what a management team confident in a 45%-conversion business does with a stock at 4.9x EBITDA.

A dividend initiation would be the single most informative announcement this company could make, and at a 50% payout on normalized free cash flow it would yield around 5%. It is listed in the tail scenarios above as upside for exactly that reason.

In depth: competitive dynamics

1. Where Versigent sits

The wiring-harness market is roughly $43B growing at about 2% a year — a slow, mature industry dominated by Japanese incumbents.

2. The number that defines the competitive question

Versigent grew 10.8% into a market growing 2%. That gap has to come from somewhere, and only three explanations are available:

• Share gain — plausible given Leoni’s distress and the general retreat of European suppliers;
• Content per vehicle — every added feature, sensor, screen and electrified subsystem adds harness content, so revenue can grow faster than unit volumes;
• Mix and pricing — including tariff and raw-material pass-through.

The 10-Q does not decompose it, which is the single most important undisclosed number for this company. Global vehicle production rose about 4% from 2024 to 2025, so Versigent is growing at roughly 2.5x industry volume. Whatever the mechanism, it is working.

3. Moats and weak spots

✅ Design-in lock. Harnesses are engineered to a specific vehicle platform and qualified through the program’s life. Switching mid-program is impractical, which makes revenue visible several years out.

✅ Global manufacturing footprint. Harness assembly is labor-intensive and must sit near low-cost labor but within reach of assembly plants. Replicating that network is slow and expensive.

⚠️ Customer concentration is severe. The top ten customers are 83% of sales, and three customers alone are 20%, 18% and 14% — 52% in three names. Losing one platform at one of them would be material; losing a customer would be structural. This is the largest single risk on this page.

⚠️ Labor intensity cuts both ways. It keeps capital requirements low — capex is 2.5% of sales — but exposes the business to wage inflation and to tariff and trade-policy shifts that change where a harness can economically be built.

❓ The long-run question is content, not volumes. If vehicle architectures move toward zonal designs and higher-voltage backbones, total harness content per vehicle could eventually fall even as electronics rise. That is a decade-long question, not a 2027 one — but it is the reason this business is priced as a melting ice cube.

In depth: valuation against peers

Versigent trades below the Tier-1 transaction range entirely, and inside the range that private buyers pay for mono-platform Tier-2 suppliers — businesses with one customer and one product. Versigent has ten customers, a global footprint and $9.3B of revenue.

Two honest reasons the discount might be deserved: customer concentration at 52% in three names is closer to a Tier-2 profile than a Tier-1 one, and two quarters of history is not enough for the market to underwrite the margin.

Neither explains a multiple this far below the peer set, and the reverse DCF result — zero growth priced in perpetuity — is the sharper way to see it.

In depth: is Versigent an acquisition target?

Not before April 1, 2028. The separation was structured to be tax-free under §355, and an acquisition of 50% or more within two years would be presumed part of a plan related to the distribution, making the spin taxable to Aptiv — a cost that would fall on Versigent under the tax matters agreement.

After that date the profile is genuinely attractive, more so than for most names this size:

The more likely outcome is that it stays independent and re-rates. At 4.9x EV/EBITDA with a growing top line, the equity does not need a buyer to work. Acquisition is optionality, not the thesis — which is the healthiest way for it to sit in a valuation.

What would change this view

Investment Scorecard

Scored on the five weighted dimensions set out in our methodology.

What the capital-allocation and value-chain work changed

Competitive Position 3.5 → 3.0, and it is the only score that moved. Setting out the bargaining position properly makes the case worse than “design-in lock” implied: the customer position is genuinely weak, and the protection is manufacturing cost rather than anything the customer cannot get elsewhere. Weighted score 3.33 → 3.20; the band holds.

Financial Profile stays at 3.0, and the capital-spending finding is why it did not fall. Capex was cut 34% into the separation and is now rising, which makes both the 2025 free cash flow and the current 21% conversion misleading in opposite directions. But the discounted cash flow already models capex at 2.8% of sales against 2.4% depreciation — above every year on record. The finding validates the model rather than correcting it, which is the opposite of what the same work did at Solstice.

The target is unchanged at $62. Nothing here touches the cash flows in the model.

First grade for this company, and grade and rating point different ways

Versigent has been carried as a completed spinoff without a grade since separation. B+ (3.20) is where the scorecard lands: a decent business, not an exceptional one. Customer concentration at 52% in three names and a mature end market are real constraints, and no amount of cheapness changes them.

The rating is BUY anyway, and the two are not in conflict. The grade measures business quality; the rating measures price. A B+ business at 7.4x normalized earnings is a better proposition than an A− business at 28x — and the bear case here, flat revenue in perpetuity at the margin this business earned through 2023–2025, is roughly the current price.

The grade takes effect with the next published report.

What would take it to A−: two or three quarters establishing that revenue growth and the 9.0% margin are a trend rather than a recovery off a soft 2024, plus any disclosure decomposing growth into share versus content. What would take it down: a customer loss, or revenue returning to the flat 2023–2025 line.